Impact Factor
1.22
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
0.07
6 total citations
h5-index
4
h5 depth signal
Cited share
6.0%
5 of 83
Total citations
6
Citation footprint
Metric signal
0.40
External metric anchor
Self-citation
0.0%
0 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
China
168
Japan
109
Germany
31
Serbia
14
United States
8
Citing Fields of Research
Drug Delivery Systems
126
Phytochemicals
103
Noncoding RNA
82
Cancer, Autophagy & Apoptosis
81
Pharmacology & Toxicology
80
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
2,536
Articles tracked across the journal lifetime
Indexed publication set
83
5 cited publications
Last 12 months
55
6.9 publications/month
Open access share
89.1%
49 OA publications in the last year
Leading citing country
China
168 citing publications
Leading citing field
Drug Delivery Systems
126 citing publications
Latest tracked publication
20 September 2026
10 recent records available
Coverage & Indexing History
v20n1,Jan. 1965-
v20n1,Jan. 1965-
Active Coverage
Active Coverage
Research Focus & Classification
Indexed Subjects
Patient Care
Anesthetic & Pain Medicine
Antibiotic & Antibacterial Agents
Allergies
Drug Delivery Systems
Pharmacology & Toxicology
Diabetes
Broad Categories
Pharmacy
MeSH Descriptors
Pharmaceutical Preparations
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.31083/pharmazie55064
Open DOI
Feasibility of a Web-Based Visualization Tool for Estimating Ibuprofen Pharmacokinetic and Pharmacodynamic Profiles to Support Self-Medication
Background: Ibuprofen is an over-the-counter (OTC) medication widely used as an antipyretic and analgesic. However, frequent use without medical supervision can lead to improper use and unintended side effects. Nonetheless, obtaining adv...
02
DOI 10.31083/pharmazie55314
Open DOI
Hydroxysafflor Yellow A Alleviates Ischemic Stroke Through Modulation of GPX4-Associated Ferroptosis: Computational Simulation and Animal Validation
Background: Ferroptosis has been recognized as an important pathological mechanism underlying ischemic stroke (IS). However, the precise mechanisms underlying the neuroprotective effects of Hydroxysafflor yellow A (HSYA) in IS remain unc...
03
DOI 10.31083/pharmazie55101
Open DOI
GA Eases Atherosclerosis by Regulating Circadian Rhythm
Background: Atherosclerosis (AS) serves as a fundamental high-risk factor associated with the development of cardiovascular diseases. There is an urgent need to investigate efficacious therapeutic strategies and molecular targets to comb...
04
DOI 10.31083/pharmazie54718
Open DOI
Lipid Metabolism, Statins and Bleeding Risk During Anticoagulant Therapy: Emerging Pharmacological Insights
Lipid metabolism, coagulation, inflammation, and vascular integrity are closely interconnected biological systems. Although statins are primarily prescribed to reduce low-density lipoprotein cholesterol (LDL-C) and prevent atheroscleroti...
05
DOI 10.31083/pharmazie53662
Open DOI
Visual Differentiation of Bupleurum marginatum var. stenophyllum From Bupleurum chinense DC. Using a PCR-Coupled G-Quadruplex Colorimetric Assay
Background: Adulteration of official Bupleurum chinense DC. with the morphologically similar Bupleurum marginatum Wall. ex DC. var. stenophyllum (Wolff) Shan et Y. Li poses safety risks. This study aimed to develop a rapid and visual met...
06
DOI 10.31083/pharmazie51720
Open DOI
The Potential Mechanism of Dihydroartemisinin in the Treatment of Thyroid Cancer Through Network Pharmacological Analysis
Background: Thyroid cancer (THCA) has recently become one of the most common endocrine malignancies worldwide. Dihydroartemisinin (DHA) exhibits well-documented antitumor activity, but its therapeutic potential in THCA remains largely un...
07
DOI 10.31083/pharmazie56983
Open DOI
HDAC1 Inhibition and Ferroptosis in Cardiac Hypertrophy: Bridging Basic Science to Clinical Translation
08
DOI 10.31083/pharmazie51355
Open DOI
Strengthening Pharmaceutical Quality Control Laboratories: Inspection-Ready Implementation of the World Health Organization Good Practices for Pharmaceutical Quality Control Laboratories and Pathways to Prequalification
Pharmaceutical quality control laboratories are essential to ensuring the safety and quality of medicines. The World Health Organization (WHO) Good Practices for Pharmaceutical Quality Control Laboratories (GPPQCL) provide a framework fo...
09
DOI 10.31083/pharmazie52565
Open DOI
Molecular Docking and Prediction of ADMET/Drug-Likeness Properties of Potential Bioactive Anti-Rheumatoid Arthritis Compounds Isolated From the Essential Oil of Capparis Spinosa L. Leaves
Background:Rheumatoid arthritis (RA) is a chronic autoimmune disease and one of the most prevalent complex inflammatory disorders. Capparis spinosa L. (C. spinosa) is recognized for its diverse medicinal properties. Traditionally, the pl...
10
DOI 10.31083/pharmazie54200
Open DOI
The Active Fraction From Polyporus umbellatus Against Hyperuricemia
Objective:This study aimed to identify the active fraction of Polyporus umbellatus extract (PUE) for the treatment of hyperuricemia (HUA) and elucidate the associated mechanism of action.Methods:HUA was induced in mice using hypoxanthine...
Bibliographical & Catalog Notes
Title from cover.
Imprint varies: Berlin : Arbeitsgemeinschaft Medizinischer Verlage GMBH, 1951- ; Verlag Volk und Gesundheit, 1959?-Apr. 1990; Verlag Gesundheit Gmbh, May 1990-Sept. 1991; Frankfurt am Main : Govi-Verlag Pharmazeutischer Verlag, Oct. 1991- ; Eschborn [Germany] : Govi-Verlag Pharmazeutischer Verlag, 1997?-
Print issues ceased with 2019.
Also issued online.
Microfilm. v. 1 (1946)-20 (1965). 20 microfilm reels : negative ; 35 mm.
In German, 1946- ; in English and German, 1972?- .
Has supplements: Die Pharmazie. Ergänzungsband, 1946-1950; Beihefte der Pharmazie, 1954-1962.